| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.09 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.1 | 0.1 |